Journals / TSK Koruyucu Hekimlik Bülteni / 2013 / Cilt: 12 - Sayı: 3

[Hiv-associated cryptococcal meningitis in resource-limited settings: Current challenges and future developments]

Kaynakların sınırlı olduğu yerlerde hıv ile birlikte görülen kriptokok menenjiti: Mevcut zorluklar ve gelecekteki gelişmeler

Pages
335–342
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Challenges particularly in resource-limited settings include inadequate diagnosis due to poor laboratory facilities and low index of suspicion, and poor availability of current effective antifungal drugs.Although studies are still on going on the use of interferon-alpha in cryptococcal meningitis, the tempo of research on development of preventive cryptococcal vaccine should also be increased.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Cryptococcal meningitis is a severe opportunistic infection in HIV disease.
📊
Key Findings & Data:Although the prevalence is declining with the expansion of antiretroviral treatment, it remains an important issue in resource-limited settings.
💡
Conclusion & Impact:Challenges particularly in resource-limited settings include inadequate diagnosis due to poor laboratory facilities and low index of suspicion, and poor availability of current effective antifungal drugs.Although studies are still on going on the use of interferon-alpha in cryptococcal meningitis, the tempo of research on development of preventive cryptococcal vaccine should also be increased.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Cryptococcal meningitis is a severe opportunistic infection in HIV disease. Although the prevalence is declining with the expansion of antiretroviral treatment, it remains an important issue in resource-limited settings. The Cochrane Database of Systematic Reviews, PubMed, EMBASE and AJOL were searched with focus on epidemiology, mycology and pathogenesis, diagnosis and treatment, and challenges in resource-limited settings, and future developments. Challenges particularly in resource-limited settings include inadequate diagnosis due to poor laboratory facilities and low index of suspicion, and poor availability of current effective antifungal drugs.Although studies are still on going on the use of interferon-alpha in cryptococcal meningitis, the tempo of research on development of preventive cryptococcal vaccine should also be increased.

Özet

Kriptokok menenjiti HIV hastalığında cidi fırastçı bir enfeksiyondur. Antiviral tedavinin çoğalması ile birlikte prevalansının azalmasına rağmen kaynakların sınırlı olduğu durumlarda önemli bir sorun olarak devam etmektedir. Epidemiyolojiye, mikoloji ve patogeneze, tanı ve tedaviye, kaynakların sınırlı olduğu yerlerdeki güçlüklere ve gelecekteki gelişmelere odaklanılarak The Cochrane Database of Systematic Reviews, PubMed, EMBASE ve AJOL veritabanları taranmıştır. Özellikle kaynakların sınırlı olduğu yerlerdeki zorluklar, zayıf laboratuar imkânlarından ve düşük kuşku indeksinden dolayı yetersiz tanıyı ve var olan etkin anrifungal tedaviye ulaşımın düşük olmasını kapsar. İnterferon-γ kullanımı ile ilgili çalışmalar devam etmekteyse de kriptoko menenjitini önlemek için kriptokok aşısı geliştirme çabaları hızlandırılmalıdır.

🔖

Cite This Article

BUSARI, O. A., OMOSANYA, O. E., BUSARI, O. E. (2013). [Hiv-associated cryptococcal meningitis in resource-limited settings: Current challenges and future developments]. TSK Koruyucu Hekimlik Bülteni, Cilt: 12 - Sayı: 3, 335–342. https://ajindex.com/articles/128647

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Bicanic T, Harrison TS. Cryptococcal meningitis. Br Med Bull 2005; 72: 99-118
  2. Robinson PA, Bauer M, Leal MA, Evans SG, Holtom PD,. Diamond DA et al. Early mycology treatment failure in AIDS associated cryptococcal meningitis. Clin Infect Dis 2000;30: 710-718
  3. Mwaba P, Mwansa J, Chintu C, Pobee J, Scarborough M, Portsmouth S, et al. Clinical presentation, natural history and cumulative death rates of 230 adults with primary cryptococcal meningitis in Zambian AIDS patients treated under local conditions. Postgrad Med J 2001; 77: 769-773
  4. Pukkila-Worley R, Mylonakis E. Epidemiology and management of cryptococcal meningitis: developments and challenges. Expert Opin Pharmacother 2008; 9: 551-556
  5. Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS 2009; 23: 525-530
  6. Moosa MY, Coovadia YM. Cryptococcal meningitis in Durban, South Africa: a comparison of clinical features, laboratory findings and outcomes HIV positive and HIV negative patients. Clin Infect Dis 1997; 24: 131-134
  7. Iyer RS, Banker DD. Cryptococcal meningitis in AIDS. Indian J Med Sci 2002; 56: 593-597
  8. Schaars CF, Meintjes GA, Morroni C, Post FA, Maartens G. Outcomes of AIDS-associated cryptococcal meningitis initially treated with 200 mg/day or 400 mg/day of fluconazole. BMC Infect Dis 2006; 6:118
  9. Mitchell DH, Sorrell TC, Allworth AM, Health CH, McGregor AM, Papanaoum K, et al. Cryptococcal disease of the CNS in immunocompetent hosts: influence of cryptococcal variety on clinical manifestations and outcome. Clin Infect Dis 1995; 20: 611-616
  10. Morgan J, McCarthy KM, Gould S, Fan K, Arthington-Skaggs B, Iqbal N, et al. Cryptococcus gattii infection: characteristics and epidemiology of cases identified in a South African province with high HIV seroprevalence, 2002-2004. Clin Infect Dis 2006; 43:1077-1080
  11. Chayakulkeeree M, Perfect JR. Cryptococcosis. Infect Dis Clin North Am 2006; 20:507-544
  12. Jarvis J N; Harrison T S. HIV associated cryptococcal meningitis. AIDS 2007; 21(16): 2119- 2129
  13. Molez JF, Ginoux PY, Asselin P, Frezil JL. Demonstration of Cryptococcus neoformans in a fatal meningeal disease in the Congo. Med Trop (Mars) 1982; 42:561-563
  14. Molez JF. The historical question of acquired immunodeficiency syndrome in the 1960s in the Congo River basin area in relation to cryptococcal meningitis. Am J Trop Med Hyg 1998; 58:273